A recent study highlighted by Hematology Advisor suggests that individuals with thalassemia are at a significantly higher risk for reduced muscle function and sarcopenia.
Sidra Medicine has officially unveiled Qatar's first advanced gene-editing therapy program, marking a historic milestone for the nation's healthcare sector.
